Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yagasaki, H.
Right arrow Articles by Yamashita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yagasaki, H.
Right arrow Articles by Yamashita, T.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Signal Transduction
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 December 2001, Vol. 98, No. 13, pp. 3650-3657

HEMATOPOIESIS

A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA

Hiroshi Yagasaki, Daiki Adachi, Tsukasa Oda, Irene Garcia-Higuera, Nii Tetteh, Alan D. D'Andrea, Makoto Futaki, Shigetaka Asano, and Takayuki Yamashita

From the Division of Genetic Diagnosis, Institute of Medical Science; and the Department of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan; and the Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Fanconi anemia (FA) is an autosomal recessive disease with congenital anomalies, bone marrow failure, and susceptibility to leukemia. Patient cells show chromosome instability and hypersensitivity to DNA cross-linking agents. At least 8 complementation groups (A-G) have been identified and 6 FA genes (for subtypes A, C, D2, E, F, and G) have been cloned. Increasing evidence indicates that a protein complex assembly of multiple FA proteins, including FANCA and FANCG, plays a crucial role in the FA pathway. Previously, it was reported that FANCA was phosphorylated in lymphoblasts from normal controls, whereas the phosphorylation was defective in those derived from patients with FA of multiple complementation groups. The present study examined phosphorylation of FANCA ectopically expressed in FANCA- cells. Several patient-derived mutations abrogated in vivo phosphorylation of FANCA in this system, suggesting that FANCA phosphorylation is associated with its function. In vitro phosphorylation studies indicated that a physiologic protein kinase for FANCA (FANCA-PK) forms a complex with the substrate. Furthermore, at least a part of FANCA-PK as well as phosphorylated FANCA were included in the FANCA/FANCG complex. Thus, FANCA-PK appears to be another component of the FA protein complex and may regulate function of FANCA. FANCA-PK was characterized as a cytoplasmic serine kinase sensitive to wortmannin. Identification of the protein kinase is expected to elucidate regulatory mechanisms that control the FA pathway.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
N. B. Collins, J. B. Wilson, T. Bush, A. Thomashevski, K. J. Roberts, N. J. Jones, and G. M. Kupfer
ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function
Blood, March 5, 2009; 113(10): 2181 - 2190.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Larder, D. Karali, N. Nelson, and P. Brown
Fanconi Anemia a Is a Nucleocytoplasmic Shuttling Molecule Required for Gonadotropin-Releasing Hormone (GnRH) Transduction of the GnRH Receptor
Endocrinology, December 1, 2006; 147(12): 5676 - 5689.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. L. Medhurst, E. H. Laghmani, J. Steltenpool, M. Ferrer, C. Fontaine, J. de Groot, M. A. Rooimans, R. J. Scheper, A. R. Meetei, W. Wang, et al.
Evidence for subcomplexes in the Fanconi anemia pathway
Blood, September 15, 2006; 108(6): 2072 - 2080.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Qiao, J. Mi, J. B. Wilson, G. Zhi, N. R. Bucheimer, N. J. Jones, and G. M. Kupfer
Phosphorylation of Fanconi Anemia (FA) Complementation Group G Protein, FANCG, at Serine 7 Is Important for Function of the FA Pathway
J. Biol. Chem., October 29, 2004; 279(44): 46035 - 46045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Thomashevski, A. A. High, M. Drozd, J. Shabanowitz, D. F. Hunt, P. A. Grant, and G. M. Kupfer
The Fanconi Anemia Core Complex Forms Four Complexes of Different Sizes in Different Subcellular Compartments
J. Biol. Chem., June 18, 2004; 279(25): 26201 - 26209.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. Adachi, T. Oda, H. Yagasaki, K. Nakasato, T. Taniguchi, A. D. D'Andrea, S. Asano, and T. Yamashita
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
Hum. Mol. Genet., December 1, 2002; 11(25): 3125 - 3134.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020